When and how should new therapies become routine clinical practice?

Area of Science:

• Clinical research methodology
• Evidence-based medicine
• Health services research

Background:

• Current processes for introducing new therapies into clinical practice are often suboptimal.
• Ineffective treatments can become widespread due to insufficient scrutiny of new therapeutic ideas.
• A structured protocol is needed to improve the implementation of novel interventions.

Purpose of the Study:

• To propose a standardized six-stage protocol for the implementation of new therapies.
• To outline a pathway from preclinical research to evidence-based clinical practice.
• To advocate for rigorous evaluation before widespread adoption of new interventions.

Main Methods:

• The proposed protocol involves six distinct stages.
• It emphasizes clinical exploration and pilot studies following preclinical research.
• Rigorous assessment using randomized clinical trials (RCTs) is central to the protocol.
• Further RCTs are recommended for intervention refinement if initial trials show promise.

Main Results:

• The protocol provides a framework for systematically evaluating new therapies.
• It prioritizes evidence generation through phased clinical trials.
• The approach aims to ensure that only effective interventions are adopted into practice.

Conclusions:

• New therapeutic interventions must undergo thorough evaluation via high-quality randomized clinical trials.
• Recommendations, teaching, and continuing education should be based on demonstrated effectiveness.
• Adoption of a standardized protocol can enhance patient safety and treatment efficacy.